Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108754 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL109289 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL6104785 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL614393 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| Dymanthine SCHEMBL8744671 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL25269808 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL225887 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL8463347 | 1.00 | — | — | |
| SCHEMBL158743 | 1.00 | — | — | |
| SCHEMBL284474 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114599746-B | Nanostructured ink compositions for inkjet printing | 昭荣化学工业株式会社 | 2024-09-03 | — | — | CN | claimed |
| EP-3080079-B1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2018-07-25 | — | — | EP | claimed |
| US-20160318860-A1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2016-11-03 | — | — | US | claimed |
| EP-3080079-A1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086565-A1 | OXIDATION OF 2-MERCAPTOETHANOL | BASF SE (DE) | 2015-06-18 | — | — | WO | claimed |
| EP-4108297-B1 | AQUEOUS SOLUTION COMPOSITION CONTAINING ORGANOSILICON COMPOUND | SHINETSU CHEMICAL CO (JP) | 2025-09-17 | — | — | EP | disclosed |
| CN-114599746-B | Nanostructured ink compositions for inkjet printing | 昭荣化学工业株式会社 | 2024-09-03 | — | — | CN | disclosed |
| CN-118251399-A | Composition containing organosilicon compound | 信越化学工业株式会社 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024044481-A1 | POLYOLEFIN ELASTOMER VITRIMER PREPARED WITH MULTI-FUNCTIONAL BORON-ESTER CROSSLINKERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11691994-B2 | Aqueous solution composition containing organosilicon compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| WO-2023095532-A1 | COMPOSITION CONTAINING ORGANOSILICON COMPOUND | 信越化学工業株式会社 | 2023-06-01 | — | — | WO | disclosed |
| US-20230021428-A1 | AQUEOUS SOLUTION COMPOSITION CONTAINING ORGANOSILICON COMPOUNDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-5118852-A | Tert-amine treatment | ETHYL CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| US-5113017-A | Process for treating tertiary amines | ETHYL CORPORATION (US) | 1992-05-12 | — | — | US | disclosed |
| US-5107028-A | Process for treating tert-amines | ETHYL CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| US-5103052-A | Tertiary amine treatment | ETHYL CORPORATION (US) | 1992-04-07 | — | — | US | disclosed |
| US-5103053-A | Process for treating tert-amines | ETHYL CORPORATION (US) | 1992-04-07 | — | — | US | disclosed |
| US-5075501-A | Mixed tert-amine oxide dihydrates | ETHYL CORPORATION (US) | 1991-12-24 | — | — | US | disclosed |
| US-5071594-A | Mixed with a builder | ETHYL CORPORATION (US) | 1991-12-10 | — | — | US | disclosed |
| US-4490455-A | STEARYL-(OCTYL- OR LAURYL-) DIMETHYL AMINE TOSYLATE | XEROX CORPORATION (US) | 1984-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691994-B2 | Aqueous solution composition containing organosilicon compounds | SI, CMA1, C9 | DNM1 3251/4885TSHR 4419/4885ALDH1A1 3005/4885 |
| US-20160318860-A1 | OXIDATION OF 2-MERCAPTOETHANOL | HAO2, GPX4, SQOR | DNM1 2773/4885TSHR 2733/4885ALDH1A1 1198/4885 |
| US-20230021428-A1 | AQUEOUS SOLUTION COMPOSITION CONTAINING ORGANOSILICON COMPOUNDS | SI, CMA1, C9 | DNM1 3251/4885TSHR 4419/4885ALDH1A1 3005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.